Response to treatment of uncommon EGFR mutations - a retrospective analysis from the German National Network Genomic Medicine Lung Cancer (nNGM) (2021) Janning M, Sueptitz J, Forstreuter A, Albers-Leischner C, Tufman A, Velthaus-Rusik JL, Reck M, et al. Conference contribution An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021) Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al. Conference contribution Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population (2021) Lorch M, Pfirrmann M, Fabisch C, Oberle L, Kohn D, Kohlbrenner K, Bruemmendorf TH, et al. Conference contribution A pre-infection laboratory score identifies cancer patients at risk for severe COVID-19: an analysis of the ADHOK coronavirus tumor registry (2021) Roesch R, Suedhoff T, Wendtner CM, Kullmann F, Schaich M, Kubin T, Mueller-Naendrup C, et al. Conference contribution Patient-reported treatment satisfaction with Rivaroxaban in cancer patients with acute venous thromboembolism - Results from the CONKO-011 trial (2021) Sinn M, Juehling A, Hellmann M, Omar M, Suedhoff T, Stahl M, Krziwanie A, et al. Conference contribution ELDORANDO - Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution The CAR-HEMATOTOX model identifies patients with a high risk for CAR T-cell related hematotoxicity and is associated with prolonged hospitalization and poor prognosis (2021) Rejeski K, Perez A, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, et al. Conference contribution Clinical phenotypes of CAR-T-cell related hematotoxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Sesques P, Berger C, Jentzsch L, Mougiakakos D, Froelich L, Bucklein , et al. Conference contribution Knowledge transfer to enhance the performance of deep learning models for automated classification of B-cell neoplasms (2021) Mallesh N, Zhao M, Meintker L, Hoellein A, Elsner F, Lueling H, Haferlach T, et al. Conference contribution Telomere length screening in young patients with head and neck squamous cell carcinoma is suitable to detect underlying inherited telomere biology disorders (2021) Tometten M, Rolles B, Klein M, Ooms M, Winnand P, Simons E, Bourgeois M, et al. Conference contribution